Wilson Sonsini - ECP

insight detail

Wilson Sonsini Advises MasterControl on $150 Million Series A

  • 12/15/22
  • Client Highlights
  • Life Sciences
  • Software

On December 15, 2022, MasterControl, a leading provider of quality and manufacturing software solutions for the life sciences, announced that it has raised $150 million in a Series A fundraising, led by Sixth Street Growth. Wilson Sonsini Goodrich & Rosati advised MasterControl on the transaction.

For nearly 30 years, MasterControl was privately grown to more than $100 million in Annual Recurring Revenue (ARR), and with this funding is valued at $1.3 billion. Proceeds from the financing will be used to accelerate the development of SaaS solutions serving the company’s global life sciences customers, which include Pfizer, Cochlear, Thermo Fisher Scientific, and more than 1,100 others worldwide.

The Wilson Sonsini team that advised MasterControl on the transaction includes:

Rezwan Pavri
Melissa Rick
Mike Moesel
Won Gi Chong
Sean Mihaljevich
Holly Hafford

Employee Benefits and Compensation
David Thomas

Myra Sutanto Shen
Anjali Krishnan

For more information, please see MasterControl's news release. Additional coverage can be found on Forbes.

ECP Attorneys:

Copyright © 2023 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.

We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content. For more information or to opt-out, visit our privacy policy.